Synthego Corporation

Healthcare ITSeries ERedwood City, USsynthego.com

Latest round

Series E

Last raised

Dec 2021

Total raised

$390M

Investors

21

About Synthego Corporation

Founded in 2012 and based in California, US, Synthego Corporation operates as a provider of genome engineering solutions that include software and synthetic RNA kits for genome editing and research. Synthego operates a CRISPR (clustered regularly interspaced short palindromic repeats)-editing platform called Eclipse. Eclipse allows its users to perform CRISPR editing which is a type of DNA sequence found in prokaryotic organisms (Bacteria) that is used to edit genes with the ability to detect and destroy DNA from similar bacteriophages when a patient gets infections. By using the platform, the company produces a list of engineered cells products called: Knockout iPS Cells, Knock-In iPS Cells, Immortalized Knockout Pool, and Immortalized Knockout Clone. The company also operates another platform called Halo, which provides gene-editing tools for biopharmaceuticals to use in their day-to-day research operations ranging from basic research to drug discovery.

Who invested in Synthego Corporation

21 investors across 5 rounds

See all investors in Synthego Corporation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Dec 31, 2021

    Amount

    $135M

    Investors

    Locked

  2. Series D

    Jun 11, 2020

    Amount

    $100M

    Investors

    Locked

  3. Series C

    Oct 9, 2018

    Amount

    $106M

    Investors

    Locked

  4. Series B

    Dec 21, 2016

    Amount

    $41M

    Investors

    Locked

  5. Series A

    Jun 26, 2013

    Amount

    $8.3M

    Investors

    Locked

Questions about Synthego Corporation

Who invested in Synthego Corporation?

Synthego Corporation has 21 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Synthego Corporation raised?

Synthego Corporation has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Synthego Corporation last raise money?

Synthego Corporation's most recent round on record is a Series E, in Dec 2021.

What does Synthego Corporation do?

Founded in 2012 and based in California, US, Synthego Corporation operates as a provider of genome engineering solutions that include software and synthetic RNA kits for genome editing and research.

Where is Synthego Corporation headquartered?

Synthego Corporation is headquartered in Redwood City, US.

Which VCs invest in companies like Synthego Corporation?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Synthego Corporation's stage. Their profiles are linked below.

Raising like Synthego Corporation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.